Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Ryland KE"'
Autor:
Squires P; Merck & Co, Inc, Rahway, NJ., Puckett J; COVIA Health Solutions, Lansdale, PA. Electronic address: justin@coviahealthsolutions.com., Ryland KE; Merck & Co, Inc, Rahway, NJ., Kamal-Bahl S; COVIA Health Solutions, Lansdale, PA. Electronic address: sachin@coviahealthsolutions.com., Raut M; Merck & Co, Inc, Rahway, NJ., Doshi J; Division of General Internal Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA., Huntington SF; Department of Internal Medicine, Section of Hematology, Yale University School of Medicine, New Haven, CT.
Publikováno v:
Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2024 Oct; Vol. 24 (10), pp. e350-e358.e1. Date of Electronic Publication: 2024 Jun 04.
Autor:
Garg M; Merck & Co., Inc., Rahway, NJ., Puckett J; COVIA Health Solutions, PA., Kamal-Bahl S; COVIA Health Solutions, PA. Electronic address: sachin@coviahealthsolutions.com., Raut M; Merck & Co., Inc., Rahway, NJ., Ryland KE; Merck & Co., Inc., Rahway, NJ., Doshi JA; Division of General Internal Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA., Huntington SF; Department of Internal Medicine, Section of Hematology, Yale University School of Medicine, New Haven, CT.
Publikováno v:
Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2024 May; Vol. 24 (5), pp. e181-e190. Date of Electronic Publication: 2024 Feb 09.
Autor:
Garg M; Merck & Co., Inc., Rahway, NJ 07065, USA., Puckett J; COVIA Health Solutions, Lansdale, PA 19446, USA., Kamal-Bahl S; COVIA Health Solutions, Lansdale, PA 19446, USA., Raut M; Merck & Co., Inc., Rahway, NJ 07065, USA., Ryland KE; Merck & Co., Inc., Rahway, NJ 07065, USA., Doshi JA; Division of General Internal Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA., Huntington SF; Department of Internal Medicine, Section of Hematology, Yale University School of Medicine, New Haven, CT 06510, USA.
Publikováno v:
Future oncology (London, England) [Future Oncol] 2024 Feb; Vol. 20 (6), pp. 317-328. Date of Electronic Publication: 2023 Dec 05.
Autor:
Squires P; Merck & Co., Inc, Rahway, NJ, USA., Puckett J; COVIA Health Solutions, Lansdale, PA, USA., Ryland KE; Merck & Co., Inc, Rahway, NJ, USA., Kamal-Bahl S; COVIA Health Solutions, Lansdale, PA, USA., Raut M; Merck & Co., Inc, Rahway, NJ, USA., Doshi JA; Division of General Internal Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Huntington SF; Department of Internal Medicine, Section of Hematology, Yale University School of Medicine, New Haven, CT, USA.
Publikováno v:
Leukemia & lymphoma [Leuk Lymphoma] 2023 Nov-Dec; Vol. 64 (11), pp. 1752-1770. Date of Electronic Publication: 2023 Jul 27.
Autor:
Ryland KE; Department of Pharmacology, University of Michigan, Ann Arbor, Michigan. Translational Oncology Program, University of Michigan, Ann Arbor, Michigan. Department of Pediatrics, University of Michigan, Ann Arbor, Michigan., Hawkins AG; Translational Oncology Program, University of Michigan, Ann Arbor, Michigan. Department of Pediatrics, University of Michigan, Ann Arbor, Michigan., Weisenberger DJ; Department of Biochemistry and Molecular Biology, University of Southern California, Los Angeles, California. Keck School of Medicine, University of Southern California, Los Angeles, California., Punj V; Keck School of Medicine, University of Southern California, Los Angeles, California., Borinstein SC; Department of Pediatrics, Vanderbilt University, Nashville, Tennessee., Laird PW; Van Andel Research Institute, Grand Rapids, Michigan., Martens JR; Department of Pharmacology and Therapeutics, University of Florida, Gainesville, Florida., Lawlor ER; Translational Oncology Program, University of Michigan, Ann Arbor, Michigan. Department of Pediatrics, University of Michigan, Ann Arbor, Michigan. Department of Pathology, University of Michigan, Ann Arbor, Michigan. elawlor@umich.edu.
Publikováno v:
Molecular cancer research : MCR [Mol Cancer Res] 2016 Jan; Vol. 14 (1), pp. 26-34. Date of Electronic Publication: 2015 Nov 16.
Autor:
Ryland KE; Department of Pharmacology, University of Michigan, Ann Arbor, MI, USA.; Translational Oncology Program, Department of Pediatrics and Communicable Diseases, University of Michigan, Ann Arbor, MI, USA., Svoboda LK; Translational Oncology Program, Department of Pediatrics and Communicable Diseases, University of Michigan, Ann Arbor, MI, USA., Vesely ED; Department of Pharmacology, University of Michigan, Ann Arbor, MI, USA., McIntyre JC; Department of Pharmacology and Therapeutics, College of Medicine, University of Florida, Gainesville, FL, USA., Zhang L; Department of Pharmacology and Therapeutics, College of Medicine, University of Florida, Gainesville, FL, USA., Martens JR; Department of Pharmacology and Therapeutics, College of Medicine, University of Florida, Gainesville, FL, USA., Lawlor ER; Translational Oncology Program, Department of Pediatrics and Communicable Diseases, University of Michigan, Ann Arbor, MI, USA.; Department of Pathology, University of Michigan, Ann Arbor, MI, USA.
Publikováno v:
Oncogene [Oncogene] 2015 Aug 27; Vol. 34 (35), pp. 4591-600. Date of Electronic Publication: 2014 Dec 01.
Autor:
Schumacher-Bass SM; From the Department of Pharmacology, University of Michigan, Ann Arbor (S.M.S.-B., E.D.V., L.Z., K.E.R., D.P.M., C.R.F., J.C.M., J.R.M.); Cardiovascular Research Institute Robin Shaw, Department of Medicine, University of California, San Francisco (P.J.C.); and Cedars-Sinai Medical Center, Los Angeles, CA (R.M.S.)., Vesely ED, Zhang L, Ryland KE, McEwen DP, Chan PJ, Frasier CR, McIntyre JC, Shaw RM, Martens JR
Publikováno v:
Circulation research [Circ Res] 2014 Mar 14; Vol. 114 (6), pp. 982-92. Date of Electronic Publication: 2014 Feb 07.